ABSTRACT
INTRODUCTION
Pro-opiomelanocortin (POMC) is the precursor polypeptide of a complex set of peptide hormones and neuroregulators that are primarily produced in the pituitary (1, 2) . These include the hormones /3-endorphin and adrenocorticotropic hormone (ACTH) which play pivotal roles in the control of mammalian homeostasis. During almost every form of chronic and acute stress ACTH is released from the pituitary in direct response to corticotrophin releasing factor (CRF). Circulating ACTH stimulates the adrenals to synthesize and secrete glucocorticoids which then negatively feedback at the hypothalamus and pituitary to supress further ACTH release. Both CRF induction and glucocorticoid repression of POMC gene expression occur in the pituitary through direct transcriptional effects (3, 4) .
Molecular genetic analysis of DNA sequences upstream of the transcription initiation site in a number of eukaryotic promoters has revealed that several conserved elements are required for accurate and efficient transcription (5) (6) (7) . The relative efficiency of a promoter harboring a TATA box is modulated by immediate upstream promoter elements such as CCAAT and GC boxes and enhancer elements that can increase transcriptional efficiency in a distance and orientation-independent manner (8) . Mutational analysis of the POMC promoter reveals that the first 720 bp of the promoter are sufficient for basal, CRF and glucocorticoidregulated transcription in vitro (4, 9, 10) and in vivo (11) . However to date the precise regions of the promoter involved in these responses have not been identified nor the interacting transacting factors identified.
In this study we provide direct evidence of a novel trans-acting factor (PO-B) that binds specifically between the TATA box and the cap site of the pro-opiomelanocortin (POMC) gene. PO-B is required for maximal transcriptional efficiency of the POMC promoter in vivo and in vitro. Our data indicate that the POMC promoter TATA box centered at -27 is able to direct correct transcription initiation of the POMC gene and that the PO-B element, unlike the recently described initiator element (12) , is unable to direct transcription initiation in the absence of a functional TATA box. The PO-B recognition sequence ( -3 to -15) does not overlap the canonical TATA binding site, and its fractionation properties are clearly different from those of the TATA binding protein TFIID (13, 14) . Formation of the RNA polymerase II initiation complex is instigated by the sequence specific binding of TFIID followed by recruitment of TFII A, B, E, and RNA polymerase II (15, 16) . PO-B does not appear to be analogous to these 'general' factors since none of them has demonstrated sequence-specific binding in the vicinity of the cap site. Recently it has been reported that repression of the thyroid stimulating a gene is mediated by a thyroid hormone receptor binding site adjacent to the TATA box (17) . However to our knowledge this region of the promoter has not been associated with sequence specific transcriptional activation.
Factors with PO-B like binding activity have also been detected in a number of cell lines in which POMC is not normally expressed, suggesting that PO-B may have a function in the regulation of other eukaryotic genes. PO-B represents the first characterized transacting activating factor known to influence POMC transcriptional efficiency in vivo and in vitro. The proximity of the PO-B binding element to the POMC cap site possibly allows PO-B to interact effectively with components of the transcription initiation complex.
RESULTS

Detection of factors that bind in the vicinity of the POMC TATA box
Maximum expression of the POMC promoter in vivo requires the first 480 op upstream of the initiation site of transcription (10) . Deletion of the promoter to position -130 reduces transcription to approximately 10% of that exhibited by the -480 construct in stable and transient transfectants of ATt-20 cells (10 and Riegel et al., manuscript in preparation). Examination of the DNA sequence downstream of the -130 region indicates that this region harbors a canonical TATA box sequence centered at -2 7 (Fig 1A) . Upstream of the TATA box (-27 to -130) are regions that bear some sequence homology to the binding sites of the CCAAT box binding factor and SPl (for review see (18) ), but the relevance of these binding sites to POMC transcription has not been determined. To identify proteins that interact with the most proximal part of the POMC promoter, gel retardation assays were performed with a fragment of the POMC promoter extending from -130 to -2 (Fig 1 A) . Nuclear extract from the C127 mouse mammary tumor cell line was used in these assays because it has been shown that the POMC promoter is active when harbored on minichromosomes in these cells (19) . Two factors were detected that bind to the POMC proximal promoter. These factors, designated PO-A and PO-B, exhibit different binding specificities since the binding of PO-A, but not PO-B, can be inhibited by a competitor fragment extending from -1 3 0 to -3 1 (Fig IB, lanes 1-5) . PO-B was competed by a fragment extending from -3 1 to -2 (see Fig 3) but binding of PO-A was unaffected (data not shown). This implied that the binding site of PO-B lay in the region -31 to -2 and could potentially be similar to the ubiquitous TATA binding factor TFIID (13) . However, this seems unlikely since a fragment of the MMTV promoter (-220 to +110) that contains a TATA binding site (14) was unable to compete for either the PO-A or PO-B binding site (Fig IB, lanes 6-10) . To determine the binding site of PO-B it was necessary to fractionate C127 nuclear extracts. A clear separation of PO-A and B was achieved by elution of factors from phosphocellulose with a linear salt gradient. PO-A fractionated in 0.3M KC1 and bound to endlabeled fragments of the POMC promoter that contained the region -31 to -7 4 relative to the transcription start site ( Fig  1C lanes 1 -4 ) . In contrast PO-B fractionated in 0.1M KC1 and only bound to the fragment extending from -74 to +82 ( Fig  1C, lanes 5, 6) but did not bind to the fragment extending from -1 3 0 to -3 1 (Fig 1C, lanes 7, 8) . This result confirmed that only fragments that contained the -31 to -2 region were capable of specifically binding PO-B.
Characterization of the PO-B binding site
We decided to delineate the PO-B binding site more thoroughly since factors binding between the TATA box and the cap site have not previously been characterized for mammalian genes transcribed by polymerase II. The techniques of methylation interference and DNase I footprinting were used for this analysis (Fig 2) . In both methods the end-labeled fragment was incubated with fractionated C127 nuclear extract and the protein-bound complex and free fragment were separated on low% acrylamide gels. The retarded PO-B-DNA complex gave an identical mobility shift in each assay and it was assumed that the interference pattern and DNase I footprint pattern obtained were due to the same factor(s). On the coding strand the PO-B binds to fragments in which the nucleotides at -3,-7 and -1 1 are unmethylated however methylation at -9,-2 or -1 does not effect the affinity of PO-B for its binding site (Fig 2A) . On the non-coding strand PO-B binds to fragments in which the -5 site is not methylated (Fig 2B) . The DNase 1 footprint of PO-B on the coding strand ( Fig 2C) extends from -4 to -15 encompassing the -5, -7 and -1 1 contacts implied by methylation interference. The 3' boundary of the PO-B binding site has an especially strong DNase 1 hypersensitive site ( Fig 2C) which taken together with the contact at -3 seen in the methylation interference analysis suggests that the PO-B binding site extends from -3 to -1 5 on the POMC promoter ( Fig 2D) . The binding site of PO-B abuts the transcription initiation site of this promoter and does not The fragment end-labelled on the coding strand was partially methylated prior to incubation with fractionated nuclear extract using conditions described in Experimental Procedures. Panel B: Methylation protection was determined for the fragment end-labelled on the non-coding strand using conditions described in Experimental Procedures. Panel C: The Hind III end-labelled fragment was incubated with fractionated nuclear extract and treated briefly with DNase I as described in Experimental Procedures. Panel D: Bases protected against methylation by PO-B are indicated by arrows for the coding (upper) and non-coding strand (lower). The underlined nucleotides represent the DNase I-resistant footprint.
of these extracts was approximately equivalent (5-10 ng/fil) so the low level of free fragment in the ATt-20 lanes might be explained by a higher affinity of PO-B for the fragment in the ATt-20 extracts. The significance of these differences will be clarified when these factors have been more extensively purified.
Transient Transfection Into ATt-20 Cells
The results described from the assays of factor binding in vitro demonstrated that the PO-B binding site was situated in a unique position in the POMC promoter between the TATA box and the cap site. The position of the binding site (-3 to -15) and the fractionation properties of this protein indicated that PO-B was not a TATA binding protein. Analysis of the sequence of the PO-B binding site also indicated that it did not share extensive homology with a weak consensus sequence of 5'-PyPyCAPyPyPyPyPy-3' that surrounds the initiation site of some TATA containing genes (22) . The PO-B site also does not share homology with the initiator element that directs faithful transcription initiation of the TATA-less promoter of the terminal deoxynucleotide transferase gene (12) . To determine if PO-B was involved in the control of transcription initiation we analyzed the effect of the 38A mutation of the PO-B binding site on the transcriptional activity of the POMC promoter in vectors harboring the luciferase reporter gene. These vectors were transiently transfected into the ATt-20 cell line that normally expresses the endogenous POMC gene. The structure of the vectors used for transient transfection experiments is shown in Fig 5A . In each transfection assay the effect of each mutation or deletion was assessed relative to the ppL36 vector. This vector contains a fragment of the POMC promoter extending from -480 to +12 relative to the transcription initiation site. Mutation of the PO-B site to a sequence that does not bind PO-B (Fig 3A) in the vector ppL38 significantly reduces luminescence to approximately 30% ( ± 5 % SEM) of ppL36 (Fig 4) . This data implies that PO-B is a transcriptional activating factor which exerts a significant effect on constitutive transcription of the POMC gene in vivo. Interestingly, a vector that contains the PO-B site but not the TATA box (ppL136) produced background luminescence levels (Fig 4) after transient transfection indicating that PO-B alone is not sufficient to direct efficient transcription but requires elements upstream of -1 8 . In the POMC promoter the TATA sequence is centered upstream of the PO-B site at -27 and it was presumed that binding of a TFIID-like factor to this site would direct correct initiation from this promoter. Surprisingly, a construct (ppL96) that harbors a mutation over the TATA box (Fig 5A) produced significant but highly variable levels (108% ± 50% SEM) of luminescence (Fig 4) compared to the ppL36 vector, suggesting that the TATA box was either nonfunctional in the POMC promoter, or more likely, that mutation of the TATA box resulted in production of a number of non-specific transcription initiation sites. Deletion of the TATA box in other promoters such as the H2A histone gene (23) leads to heterogenous start site formation in vivo without a reduction in overall transcription. It is clear from the transient transfection data that mutation of the POMC TATA box and the PO-B site lead to different phenotypes in vivo and that the binding at these two sites is separable and distinct. This conclusion is also supported by the fact that a mutation upstream of the PO-B site between -1 6 and -22 (ppL98) that does not alter the canonical TATA binding sequence is phenotypically the same as ppL36 after transient transfection and also in in vitro transcription assays (data not shown).
POMC Transcription In Vitro
To analyze the mechanism of PO-B activation of transcription in more detail, in vitro transcription assays were performed using nuclear extracts from Hela, ATt-20 and C127 cells. Efficient transcription in vitro is not highly dependent on enhancer sequences and offers a useful system for studying the effects of mutations on basal promoter elements. The vectors used in the in vivo transfection experiments ( Fig 5A) were also used as supercoiled DNA templates for the transcription assays. The quantity of mRNA produced and the transcription start site were analyzed using primer extension analysis. The primer employed for this assay was situated in the luciferase coding region giving a predicted extension product of 169 bp with the ppLw and 99 bp with the ppL36, ppL38, ppL96 and ppL136 downstream deletion mutants (Fig 5A) . In in vitro transcription with extracts from HeLa and C127 cells the ppLw vector produced a single correctly initiated transcript (Fig 5B, lanes 1, 6, 16 ). These cell lines do not correctly express the POMC gene in vivo unless a cis-acting enhancer element is present in the vector (21) . However transcription of POMC in vitro is not dependent on these enhancer elements and it appears that all the factors required for basal promoter complex formation are present in HeLa and C127 nuclear extracts. In ATt-20 cells initiation occurred at two distinct sites several base pairs apart in the vectors tested ( Fig 5B, lanes  11 -15) . This has also been observed with other primers located closer to the POMC start site (data not shown) and occurs consistently in transcription assays using extracts from the ATt-20 cells. In vivo initiation of the POMC gene in ATt-20 cells also occurs at sites several base pairs apart (our unpublished observation and (10)) and it appears the extracts in vitro are capable of reproducing this effect.
Mutation of the PO-B site (ppL38) reduced transcriptional efficiency of the promoter 4-6 fold (as assayed by laser scanning densitometry on at least two separate transcription experiments) relative to ppL36 in extracts from all three cell types (Fig 5B,  lanes 3 vs 4, 8 vs 9 , 13 vs 14 and 17 vs 18), mirroring the effects of this mutation in vivo (Fig 4) and demonstrating that PO-B is a trans-acting factor that has significant stimulatory effect on transcriptional efficiency in vivo and in vitro. However, unlike the initiator element described for TATA-less promoters (12) the PO-B factor was not capable of directing transcription initiation in the absence of a TATA box because no specific initiation was detected with the ppL136 construct in HeLa (Fig 5B, lane 2) or ATt-20 extracts (Fig 5B, lane 12) . Mutation of the TATA box (ppL96) produced a number of novel transcription start sites ( Fig  5B, lanes 5, 10 and 15 ) but no specifically initiated transcript of 99bp. Transcription did not initiate consistently from the same site within the ppL96 construct and the levels of transcription products observed were variable. Comparison of transcription products from the ppL136 and ppL96 vectors demonstrates a qualitative and quantitative difference in non-specific transcripts produced (for example, compare lanes 7 and 10). The increased and variable non-specific transcription from the ppL96 vector observed in vitro is consistent with the high levels of luminescence observed from this vector in in vivo transfection assays (Fig 4) .
DISCUSSION
In the present study we have characterized a transcription factor PO-B that binds with sequence specificity between the POMC TATA box and cap site. Mutation of the PO-B site decreases POMC basal transcription by 70% in vivo and in vitro and clearly represents an important trans-activating factor for this promoter. The PO-B element lies within the first 720 bp of the POMC promoter an area previously shown to be sufficient for CRF induction (4), glucocorticoid repression (9) and tissue-specific regulation (10) . To date however the transacting factors involved in these responses have not been clearly defined. The PO-B element is not involved in glucocorticoid-repression of POMC gene expression (Riegel et al., manuscript in preparation) but its role in other transcriptional responses is not known. Although the PO-B binding site is close to the TATA element three lines of evidence clearly distinguish the PO-B protein from the TATA-binding protein TFIID. The binding site ( -3 to -15) does not overlap the TATA box. In previous analyses of the TATA binding activity, variation has been observed in the extent to which the footprint extends over the initiation region (14, 15) , but the TATA site itself is invariably recognized in the footprint. The TATA motif clearly is not part of the PO-B recognition site. Secondly, the PO-B protein fractionates differentially from TFIID on phosphocellulose chromatography. TFIID elutes from this matrix in 0.5-1.0 M KCL (13, 14) whereas PO-B elutes at 0.1 M KC1. Finally, the transcription stimulatory properties of the two factors are different. Mutations in the PO-B site depress transcription both in vivo and in vitro, while lesions in the POMC TATA motif have a variable effect on efficiency, but markedly alter initiation site selection. The differences in fractionation also indicate that PO-B is not acting as TFIID through a non-TATA binding region, as reported previously (24) for the adenovirus IVa2 promoter.
The binding site for the PO-B protein has been defined by a combination of DNA-protein binding techniques using crude and fractionated extracts. The recognition sequence (5'-AGAAGAGTGACA-3') does not share significant homology with the canonical binding sites for transcription factors that have been previously characterized (25) . The PO-B recognition site is highly conserved with regard to position and sequence in the POMC promoter from different species (26, 27) . Factors that bind to the PO-B recognition sequence are present in many cell lines that do not express the POMC gene, implying that these proteins are likely to be involved in the regulation of genes other than POMC.
Mutation of the PO-B binding site causes a significant decrease in transcriptional efficiency in vivo and in vitro, but does not alter the position of transcription initiation. Smale and Baltimore (12) have recently described an element (initiator) that apparently directs transcription initiation in TATA-less promoters. Initiation of transcription in the POMC gene appears to be entirely dependent on the TATA element situated at -27, since mutation of this site leads to a number of aberrant start sites in vitro.
Furthermore, the binding site for PO-B is upstream from the inferred site of action for the initiator element. PO-B is therefore to be distinguished from the putative initiator element. Accurate and efficient transcription initiation of POMC occurs in nuclear extracts from cell lines that do not express POMC in vivo, suggesting that in vitro transcription of this gene is not dependent on the activity of more distant enhancer elements. In vivo, transcription of this gene in C127 (20, 21) and L cells (28) is dependent on the presence of a strong enhancer.
RNA polymerase II transcription initiation has been shown to occur by a number of discrete steps (15, 16, (29) (30) (31) . Sequence specific binding of TFIID is followed by recruitment of TFIIA, B, E, and RNA polymerase II, forming a heparin-resistant complex. After addition of nucleoside triphosphates, this preinitiation complex can initiate transcription (32, 33) . Assembly of the complex can be followed by the changes in the DNAse 1 protected sequences in the vicinity of the CAP site, the final complex covering an area extending from approximately -40 to +35 (15, 16) . Since the PO-B recognition sequence lies within this area, it seems likely that the PO-B protein may interact with TFIID and/or other general initiation factors to facilitate formation of the initiation complex by direct protein-protein interactions (34) . Alternatively PO-B may functionally replace one of the general initiation factors. We do not however believe that PO-B is TFII A,B or E since none of these proteins has demonstrated sequence-specific binding.
The extent of TATA region protection by TFIID can vary considerably. In the adenovirus E4 promoter, the TFIID footprint extends over a small region upstream from the cap site (15) . In other promoters, however, the protected region covers a larger area encompassing the cap site (13, 14) . The precise boundaries of TFIID on the POMC promoter have not been defined, although a weak exonuclease III boundary at position -2 0 has been detected with crude nuclear extracts in vitro (unpublished observation). The position of this Exo III block is consistent with the 3' boundary of a relatively short TATA region interaction. The presence of a discrete binding site for PO-B adjacent to the POMC promoter cap site would then be compatible with a minimal TFIID interaction, protecting sequences upstream of -1 5 in the POMC promoter.
The precise mechanism of action for the PO-B factor will require further investigation in vitro with purified fractions. The results reported here indicate that PO-B recognizes DNA sequences immediately upstream of the initiation site, and is required in combination with other members of the initiation complex for efficient and accurate transcription from the POMC promoter.
EXPERIMENTAL PROCEDURES
Recombinant Plasmids
All vectors were derived from a plasmid pJA115 (21) that contains a Sal I-Hind III chimeric fragment of the rat POMC promoter extending from approximately -720 to +60 (with respect to the RNA initiation site), plus a 24bp segment of SV40 early 5'-untranslated sequences, inserted into the Hinc II-Hind III multiple cloning sites of the vector pGEM 1 (Promega Biotech). To obtain firefly luciferase expression vectors the Bgl II(-480)-Hind III( + 87) fragment of pJA115 was inserted into the Bgll-Hind III site of the luciferase expression vector pxpl (35) creating plasmid pplw.
Mutation of the POMC promoter in the vicinity of the transcription initiation site was achieved using oligonucleotide directed mutagenesis. 
Preparation of Crude and Fractionated Nuclear Extracts
Nuclear extracts for the gel electrophoresis binding assay were prepared from the C127 mouse mammary adenocarcinoma, the ATt-20 mouse pituitary and Hela cell lines by the method of Dignam et al (1983) (36) . The protein concentration of the extract was in the range of 5-20 mg/ml and was stored at -80°C for several months without loss of activity. Pooled C127 nuclear extract was fractionated over a phosphocellulose Pll ion exchange column with a linear gradient between 0.1 and 0.4M KC1 (14) . Fractions were assayed for DNA binding activity using the gel electrophoresis binding assay, the PO-B binding factor eluted predominantly in the 0.1M KG fraction. For methylation interference and DNase 1 footprinting, fractions containing PO-B were concentrated several fold by ultrafiltration. For in vitro transcription assays whole cell extracts were prepared from C127, ATt-20 and HeLa cells by the method of Manley et al., 1980 (37) .
DNA Probes
Regions of the POMC promoter that contained the PO-B binding site plus upstream control regions were cleaved from plasmid ppomlo with various restriction enzymes [Sstll-Avail (-130 to -2 ) , Sstn-Pstl (-130 to -31) and HaeH-Hindni (-74 to +87)]. Radioactive probes were prepared by end-labeling DNA fragments with Klenow and alpha-32 P-dATP or with T4 polynucleotide kinase and gamma-32 P-ATP and purified with polyacrylamide gel electrophoresis by standard techniques (7) . Two synthetic oligonucleotides, one containing the wild-type PO-B site (5-'AAGAAGAGAGAAGAGTGACAGGGACCAA-3' (36A) and the mutated PO-B site (5'-AAGAAGTTCCTGTCCC-ACTGGGGACCAA-3'(38A) were reannealed with their respective complimentary strands and used as either unlabeled competitor or radiolabeled probes in the gel electrophoresis DNA binding assay. A fragment of the mouse mammary tumor virus (MMTV) promoter (-220 to +110) that contained the TATA binding site and the cap site was cleaved as a Bam Hl-HindlH fragment from plasmid PM50 as described previously (14) .
Gel Retardation DNA Binding Assay Protein-DNA complexes were resolved on non-denaturing 4% low ionic strength gels using conditions similar to those originally described by Fried and Crothers (1981) (38) . Nuclear extracts (5-20 fig) were incubated with end-labelled fragments (approximately 10 fmol) in the presence of l^g of poly(dl-dC)-(dl-dC) as non-specific competitor in a final volume of 20/il for 20 min at 25°C. Such reactions contained lOmM Tris pH 7.4, lOOmM KC1, 5mM MgCl 2 , 5% glycerol, lmM DTT, lmM EDTA. In some reactions unlabeled specific or nonspecific fragments or oligonucleotides were also added. Binding reaction were subjected to electrophoresis for 3-5 hrs at lOV/cm in 12.5mM Tris borate-3mM EDTA running buffer. Following electrophoresis, gels were dried onto Whatman 3MM and retarded complexes detected by autoradiography.
Methylation Interference Assay
End-labeled DNA probes were partially methylated using dimethylsulfate (39) and incubated with C127 nuclear extracts as described for the gel electrophoresis binding assay. These reactions were scaled up to a final volume of 60 /tl containing approximately 30 fmol (200xl0 3 -400xl0 3 cpm) of probe DNA. After incubation for 15 min at 15°C, the reaction mix was electrophoresed for 4 -5 hrs on a native 4% low salt acrylamide gel. DNA was transferred from the gel by electrophoresis onto Whatman DEAE (DE-51) paper for 16 hrs at 18V. The free and retarded bands were visualized by autoradiography of the wet paper, and the complexes were excised and the DNA eluted by incubation in 400/tl 20 mM Tris pH 7.8, 2 mM EDTA, 1.5 M NaCl for 3 -4 hrs at 37°C. The DNA was purified, piperidine cleaved and then analysed on 5% or 8% sequencing gels.
Dnase I Footprint analysis
End-labeled DNA probes were incubated with fractionated extracts from C127 cells that contained the PO-B factor using conditions described for the gel electrophoresis binding assay. The final reaction volume of these incubates was 30 /il. After incubation for 20 min at 25°C an equal volume of lOmM MgCl 2 and lmM CaCl 2 was added to the mixture and digestion was initiated by addition of 5 n\ of DNase I (1/ig/pl; Worthington) for 1 min at 25°C. The reaction was terminated by addition of 5^1 EDTA (500mM) and retarded and free complexes were resolved on native 4% acrylamide gels. The complexes were then transferred to DEAE cellulose and eluted as described for the methylation interference assay. After purification the DNA was analy on 5% or 8% sequencing gels.
In Vitro Transcription Reactions
In vitro transcriptions were performed in a total volume of 15 /il, containing 7.5 ill of whole cell extract, lmM nucleoside triphosphates, 0.2-0.6 /tg supercoiled template DNA, 20mM
Hepes pH 7.9, 100 mM KC1, 12.5mM MgCl 2 , O.lmM EDTA, 17% glycerol, and 2mM DTT. After incubation for 60 min at 31°C, the reaction was terminated by addition of 285 /*1 of 0.05% SDS, 150 mM NaCl and lOmM Tris pH 7.5. RNA was purified by two extractions in phenol xhJoroform (1:1) and one extraction in chloroform, and precipitated with two volumes of ethanol.
The 5' end of the mRNA was mapped using a primer extension assay. A 30bp primer in the luciferase coding region (5'-GATAG-AATGGCGCCGGGCCTTTCTTTATGT-3') was end-labelled with polynucleotide kinase and 0.1 pmol of the radioactive probe was co-precipitated with RNA from each reaction with ethanol. The pellet was resuspended in 4.5 /i\ of 55OmM Tris pH 8.3, 450mM KC1, heated to 75°C for 10 min, and allowed to cool to 43°C over 1-2 hrs. After primer annealing to RNA, the reaction volume was increased to a final volume of 50/tl containing Tris (50mM pH 8.3), KC1 (40mM), MgCl 2 (8mM), DTT (lmM), nucleotide triphosphates (0.2mM), and reverse transcriptase (10 units). Extension of primer proceeded for 1 hr at 43 °C and was terminated by addition of NaOH and EDTA at 70°C for 30 min. The reactions were neutralized by addition of acetic acid, ethanol precipitated and electrophoresed on 8-12% sequencing gels. The relative intensities of the bands obtained after autoradiography were quantitated using a laser scanning densitometer.
Cell Culture and Transfections
ATt-20, HeLa and C127 (ATCC cell lines) were propagated in Dulbecco's modified Eagle medium supplemented with 10% fetal calf serum. For preparation of nuclear extracts, cells were harvested at 50-60% confluence.
For transient transfection of ATt-20 cells, approximately 3X10 5 cells were plated in 35mm dishes 48 hrs prior to transfection. One day and 2 hrs prior to transfection, the cells were provided with fresh media. Liposome-mediated transient transfection of DNA was performed using a method described previously (40) . Cells were washed twice in Optimem (BRL), followed by treatment with a liposome (lipofectin, BRL):DNA (1:1) mix. In general, 1 ml of optimem containing 5 -10 /xg of supercoiled plasmid DNA and 5 -10 /il of liposome (lipofectin; BRL) was added to each dish. Five hours later 3 ml of media was added. Media was changed again at 24 hrs and cells were harvested 48 hrs after transfection. Luciferase assays were performed as described previously (41) Luminescence was determined for 10 /tl of extract plus 100 lA of luciferin reagent. Total light emitted for 60 sec was measured in a Berthold Biolumat LB9500C luminometer at 25 °C.
